Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 14/20 | 0.45 |
| ▸ | PNLIP | P16233 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2489963 | 0.91 | PTGDR2 (0.50) | PTGDR2PNLIPPOLBNPC1RAB9A | |
| SCHEMBL2489639 | 0.89 | PTGDR2 (0.45) | PTGDR2PNLIPPOLBNPC1RAB9A | |
| SCHEMBL2489612 | 0.87 | PTGDR2 (0.48) | PTGDR2GRM5 | |
| SCHEMBL2492508 | 0.86 | PTGDR2 (0.48) | PTGDR2GRM5NPC1RAB9ACASP3 | |
| SCHEMBL2490747 | 0.85 | PTGDR2 (0.61) | PTGDR2GRM5 | |
| SCHEMBL2489767 | 0.85 | PTGDR2 (0.44) | PTGDR2GRM5NPC1RAB9AMAOB | |
| SCHEMBL2487257 | 0.83 | PTGDR2 (0.51) | PTGDR2GRM5 | |
| SCHEMBL2486854 | 0.83 | PTGDR2 (0.49) | PTGDR2GRM5NPC1RAB9ACASP3 | |
| SCHEMBL2131204 | 0.83 | PTGDR2 (0.67) | PTGDR2 | |
| SCHEMBL17818014 | 0.82 | PTGDR2 (0.54) | PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2379535-A1 | 7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES | Array Biopharma Inc. (US) | 2011-10-26 | — | — | EP | disclosed |